FMP

FMP

Enter

CYTH - Cyclo Therapeutics, ...

Financial Summary of Cyclo Therapeutics, Inc.(CYTH), Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based produc

photo-url-https://financialmodelingprep.com/image-stock/CYTH.png

Cyclo Therapeutics, Inc.

CYTH

NASDAQ

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

1.35 USD

-0.05 (-3.7%)

About

ceo

Mr. N. Scott Fine

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

website

https://www.cyclotherapeutics.com

exchange

NASDAQ

Description

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated...

CIK

0000922247

ISIN

US23254X2018

CUSIP

550241103

Address

6714 NW 16th Street

Phone

386 418 8060

Country

US

Employee

8

IPO Date

May 3, 2000

Summary

CIK

0000922247

Exchange

NASDAQ

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

550241103

ISIN

US23254X2018

Country

US

Price

1.35

Beta

-0.18

Volume Avg.

92.74k

Market Cap

38.63M

Shares

-

52-Week

0.89-2.57

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.1

P/B

-

Website

https://www.cyclotherapeutics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest CYTH News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep